Trial Profile
Clinical Trials Insight: 700039500
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2008
Price :
$35
*
At a glance
- Drugs Balapiravir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Roche
- 04 Dec 2008 New trial record.